key: cord-0772668-e7vbrh66
authors: Razi Zaidi, Syed Tabish; Hasan, Syed Shahzad
title: Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey
date: 2020-07-09
journal: Res Social Adm Pharm
DOI: 10.1016/j.sapharm.2020.07.006
sha: 455c14079ca19ae952c0219dc62b8e0e52a933b4
doc_id: 772668
cord_uid: e7vbrh66

INTRODUCTION: Coronavirus disease (COVID19) has adversely affected the delivery of various health services. Little is known about the impact of COVID19 on pharmacy services across the United Kingdom (UK). We surveyed community pharmacists across the UK to understand their protective practices, professional and general well-being, and the delivery of pharmacy services during the COVID19 pandemic. METHODS: Community pharmacists were invited to participate in a cross-sectional survey via the nationwide weekly newsletter of Pharmaceutical Services Negotiating Committee and the local pharmaceutical committees during the second week of May 2020. The survey remained open for 4 weeks. RESULTS: A total of 206 pharmacists responded to the survey with representations from England, Northern Ireland, Scotland, and Wales. The majority of pharmacists (>75% or above) reported an increase in customer traffic to their pharmacy and were asking relevant questions from patients with flu-like symptoms before signposting them to the appropriate care. Most pharmacists (>85%) were maintaining a safe distance of 2 m from customers and 72% were wearing an N95 protective mask and 28% were using protective gloves and apron in addition to safe distancing and protective masks. Ninety-nine percent of pharmacists reported drug shortages with 38% and 26% reported significant drug shortages and critical drug shortages causing disruptions beyond over the counter medicines. Eighty-nine percent pharmacists reported inappropriate behaviour from patients or carers with 31% and 16% reported it to be a regular or frequent problem, respectively. Fifty-three% of pharmacists were willing to offer their assistance for mass testing of COVID19 antibodies if adequate training and reimbursement are provided. CONCLUSION: Community pharmacists in the UK are facing considerable challenges in terms of personal protection and the delivery of pharmacy services. Inappropriate behaviour from patients and carers towards community pharmacists require urgent attention to ensure a safe working place for all community pharmacists.

Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has created new norms in almost every aspect of our daily lives from social interactions with family and friends to seeking essential healthcare services. The unprecedented rate of novel coronavirus disease (COVID-19) spread has taken most public health authority by surprise as the total number of confirmed cases now stands at over 10 million. 1 The average mortality of the COVID-19 is substantially higher than the seasonal flu with over 500,000 of over 5 million cases with an outcome that is now deceased. 1 Europe is the worst affected region in the world in terms of COVID19 related mortality accounting for 43% of all deaths reported worldwide. 1 Within Europe, the mortality is hugely varied though the United Kingdom (UK), Italy, and Spain are hardest hit countries representing one-quarter of COVID19 related deaths despite representing around 1/10 th of the total numbers of cases, globally. 1

Owing to the massive increase in the newly reported cases, as well as COVID19 related mortality, the Government of the United Kingdom on the 23 rd of March, 2020 imposed a complete lockdown of non-essential services to protect the NHS and limit the spread of COVID-19. 2 Significant food and medicines shortages were reported in the media and there was a general feeling of chaos and uncertainty during the earlier phase of the lockdown. 3 Community pharmacies remained open during these uncertain times and there were reports of inappropriate behaviour by the general public and patients towards community pharmacy staff. 4 Community pharmacists play an important role in providing a range of services to the members of the public and patients in the UK. Pharmacists are the most accessible trained healthcare professionals who are the first point of contact for minor ailments and cold and flu-like symptoms in the UK, 5 and therefore, are likely to see patients with suspected COVID19. Appropriate safeguarding of community pharmacists during the COVID19 pandemic is vital for the continuity of essential pharmacy services. Given the rapid and unprecedented spread of the disease and the conflicting recommendations on personal protective equipment use, 6 little information is available on the impact of COVID19 on the practices of community pharmacists. Additionally, amid reported abuse and inappropriate behaviour towards community pharmacy personnel, 4 it was important to gauge the extent and seriousness of such behaviour. Community pharmacies in the UK vary considerably in terms of size, design, and location, and therefore, some of the community pharmacists may be at a higher risk of contracting COVID19 than others. A survey study of the UK community pharmacists is needed to assess the impact of COVID19 on their professional practice and to share innovative approaches that individual pharmacists may have been opted for during these uncertain times.

Our study aimed to gauge the impact of COVID19 on the practices and general wellbeing of the UK community pharmacists. The specific objectives were:

1. To identify the types of protective measures and innovation in service delivery that are in place to minimise the spread of COVID19 to pharmacy staff and the members of public 2. To gauge the level of anxiety amongst the UK community pharmacists due to COVID19

This was a cross-sectional study conducted among community pharmacists providing pharmacy services in communities located in England, Northern Ireland, Scotland, and Wales. Pharmacists who met the inclusion criteria including registration as a pharmacist in the UK, working in a community pharmacy and those who had provided informed consent were recruited.

Ethical approval was obtained from the School of Applied Sciences Research and Ethics Committee at the University of Huddersfield [Research ID: SAS-SREIC 05.05.20-1]. All collected data were stored in a password-protected file accessible only to the researchers. The study results are reported as deidentified data and no personal data was disclosed.

Though all registered pharmacists working in community pharmacy were invited to participate, the sample size was estimated. There are 11,700 community pharmacies in England, 532 in Northern Ireland, 1250 in Scotland, and 716 in Wales. 7-10 Over 30,000 pharmacists are working in the community pharmacies in England, 11 and though such number is not available for the other three countries, a similar ratio of Pharmacy to Pharmacist from England (i.e. 1: 2.5) will yield an approximate number of 1300, 3100 and 1800 for Northern Ireland, Scotland and Wales, respectively.

Assuming a total number of over 36,000 community pharmacists in the UK, we needed 195 responses to achieve a 95% Confidence level and 7% confidence that the observed responses are within 7% of the representative responses of all pharmacists. 12 STRZ developed the initial pool of survey questions based on a prior study, 6 anecdotal reports of inappropriate behaviour towards pharmacists, 4 and, his own experience of community pharmacy practice. The survey was reviewed by SSH and two more pharmacy academics with experience in community pharmacy practice and research. The initial item pool was modified and forwarded to four experienced community pharmacists for testing and piloting. The tool was finalised after the feedback from the four community pharmacists and was hosted online at onlinesurveys.ac.uk from 4 th -30 th of May 2020. An invitation email with a QR code and a survey link were used to recruit community pharmacists via the weekly newsletter of the Pharmaceutical Services Negotiation Committee (PSNC), a national professional body representing all community pharmacies in the UK.

Local Pharmaceutical Committees were also invited via individual personalised emails to distribute the tool to the community pharmacies in their catchment during the first two weeks of the survey.

Twitter posts were also used to promote the survey through personal accounts of STRZ and SH during week one and week three of the survey tagging professional pharmacy organisations such as Royal Pharmaceutical Society, and National Pharmacy Association. Our requests for a reminder were understandably denied by the PSNC and the several local pharmaceutical committees did not respond to our request presumably to minimise distractions for community pharmacists during this highly stressful period.

The data were analysed using Statistical Package for Social Sciences (SPSS) (version 24) with 0.05 as the level of significance. Descriptive statistics were used to present percentages, frequencies, mean and standard deviation. For all of the categorical data to be stated, the frequency of patients per category was analysed and recorded with the associated percentages. For the continuous data, mean and standard deviation with any associated range were analysed and recorded.

A total of 206 community pharmacists from England, Northern Ireland, Scotland, and Wales participated in this survey. These included 182 participants from England (91%), six from Wales (3%), six from Scotland (3%), and six from Northern Ireland (3%) (Figure 1) . In England, highest responses were obtained from Greater London (15.5%) and North West England (15.5%) Table 1 presents the characteristics of participating pharmacists and pharmacies. The mean age of the participants was 45.6 (11.6) with similar proportions of male and female participants. The majority of the participants were working as either manager or sole pharmacist (59%). Most of the pharmacies were located at the high street (44%) and were either large-chain (40.5%) or independent pharmacy (33.3%). More than two-third community pharmacists noticed an increase in customer traffic amid COVID-19 pandemic. 

In response to question about major logistic issues with regards to the supply of the medicines amid COVID-19, 37% of pharmacists reported significant drug shortages including paracetamol, over the counter cold/flu remedies, commonly used antibiotics and another 26% reported critical drug shortages creating major problems where they are unable to supply patients with their regular medicines (Figure 2) .

When asked about receiving queries from patients, customers, or members of the public concerning the potential medicines for COVID-19, the majority of the pharmacists reported hydroxychloroquine, chloroquine, and azithromycin. In response to reading or researching information about COVID-19 and the sources of information they have been using, majority of the pharmacists reported reading scientific journals (69%), followed by BBC website (64%), Social media (35%) and Newspaper (33%). More than two-thirds of the participating community pharmacists experienced unusual behaviour in the pharmacy due to increased anxiety and frustration in the general public: 25% experience minor considered listening to music as moderately or very helpful. The majority of the pharmacist considered medicines to overcome anxiety (83%), meditation and prayers (51%), and an online forum for pharmacists as not applicable. Table 2 presents participants' anxiety or worries about working in a community pharmacy after the COVID19 outbreak. The majority of the participants raised major concerns that they will get the COVID-19 (39%), and that they will get my family or friends infected with COVID-19 (58%). About 37% of the participants showed minor concerns towards other staff in the pharmacy not taking precautions. Table 3 presents the precautionary measures taken by pharmacists before consulting the patients. No specific precautions at all, I interact with the patient as I used to before the outbreak 2 1.0 I maintain a safe distance of 2 meters but do not take any additional precautions 28 13.6 I maintain a safe distance of 2 meters and use a protective mask (surgical or N95) 88 42.7 I maintain a safe distance of 2 meters, use a protective mask (surgical or N95), and use gloves and a plastic apron 57 27.7

There are specific policy and procedures in place and all staff are following these strictly 102 49.5 There are specific policy and procedures in place though not all staff are following these strictly 66 32.0 There is a protective hard plastic or glass screen (similar to the one seen in banks) being installed to shield pharmacy 156 75.7 Cash is not accepted as a payment method and only contactless card payments are accepted 

COVID19 has a significant impact on the ongoing operations of pharmacies and the general wellbeing of community pharmacists in the UK. Despite the unprecedented stress and logistic issues that community pharmacists are facing, we received a good response and survey completion indicating a strong desire from pharmacists to communicate their concerns. Several findings from this first survey of the UK community pharmacists are worthy of further deliberations.

Critical drug shortages to an extent where pharmacists were unable to provide patients with their regular medicines were noted by more than half of the respondents. The lack of continual care for patients on chronic medicines for primary or secondary prevention of heart disease, or management of diseases such as asthma, chronic obstructive pulmonary disease, and diabetes may have serious consequences for patients. In addition, the lack of appropriate care may cause exacerbations of chronic disease leading to a higher risk of presentations at the accident and emergency departments of local hospitals which are already under stress due to the pandemic. While short term shortages were unavoidable due to the unprecedented nature of COVID19 pandemic, careful considerations for drug shortages should be included in any future planning with regards to community pharmacy contracts to ensure a continual supply of chronic medicines to patients.

The majority of pharmacists reported a change in customers' behaviour with nearly half (45%) found it to be more than an isolated problem. More than 60% of the pharmacists reported inappropriate behaviour of the patients and their caregivers to be either a moderate or major concern making them anxious or worried while doing their job. Anecdotal reports of inappropriate behaviour towards community pharmacists have been reported by the British Broadcasting service though our study is the first to document the issue systematically across the UK. 3 It is interesting to note that the inappropriate behaviour towards pharmacists was mainly due to drug shortages and rationing of over the counter sale to ensure equitable access to these medicines and discourage hoarding of basic medicines by panic buyers. Community pharmacies are often criticised by the public and other healthcare professionals as part of the health system that is too focused on generating profits. 13 Nevertheless, community pharmacists were facing inappropriate behaviour by the public for ensuring equitable access to medicines for all.

All except a small number (8%) of pharmacists were anxious about working in the pharmacy during COVID19 and 42% of them noted this as a significant concern to them. Getting COVID19 or being a cause of infection for their loved ones was a major concern for most pharmacists. This is quite understandable as many healthcare professionals in the UK have contracted COVID19 at work including over 300 NHS staff and care workers who have lost their lives to the pandemic. 14 Healthcare system transmission places healthcare workers at a much greater risk than community transmission and this is true with other countries such as China, Spain, and Italy. 15 The majority of pharmacists (90%) felt that their contribution is unrecognised by the NHS, government, public, or pharmacy owners. Community pharmacists are facing challenging times in the UK with constant cuts in their funding and an ever-changing structure of pharmacy services in the primary care. 16 Regarding preventative measures, respondents in our study highlighted several measures that were taken at the pharmacy and individual level. The most commonly followed precautionary measures at a pharmacy level was the entry of limited customers in a given time to maintain social distancing rules. One of the major issues with community pharmacies is the limited space or staff to practically implement social distancing in their premises at all times. 6 20 . These differences may be explained by the significant differences in the prevalence of COVID19 in all three countries. As noted above, Kosova has experienced relatively fewer numbers of confirmed COVID19 cases compared to the UK whereas Italy was the hardest-hit country in Europe at the time of our study 1 .

There are some strengths and weaknesses associated with our study. This is the first nationwide survey assessing the impact of COVID19 on the professional and general well-being of community pharmacists, their anxiety, and protective measures across the UK. Despite achieving a reasonable sample of community pharmacists across the UK, representations from Wales, Northern Ireland and Scotland were limited. Given the significant stress community pharmacists have been under, our request for a reminder was understandably denied by the PSNC. Therefore, our sample may have a respondent bias.

This is the first national survey of the impact of COVID19 on pharmacy services delivery and the general and professional wellbeing of community pharmacists across the UK. The study identified genuine concerns around public behaviour towards pharmacy staff and critical drug shortages that have impacted the continuity of care for patients. Pharmacy organisations and commissioners of pharmacy services should consider our findings while developing a coordinated response to ensure the ongoing safety and wellbeing of community pharmacists.

COVID-19 CORONAVIRUS PANDEMIC

Coronavirus: Strict new curbs on life in UK announced by PM

Inside a community pharmacy under pressure

UK pharmacists facing abuse and violence during lockdown

Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review

Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures? Res Social Adm Pharm. 2020. 7. Goundrey-Smith S. The Connected Community Pharmacy: Benefits for Healthcare and Implications for Health Policy

Community Pharmacy. Health Funding in Northern Ireland

Essential facts, stats and quotes relating to pharmacy and pharmacy professionals

Sample Size Calculator

Do we really need pharmacies? In. Pulse Today: Pulse Today

We don't know exactly how many NHS workers have died from Covid-19

COVID-19 How many Healthcare workers are infected?

Court of Appeal upholds ruling on community pharmacy cuts

Anonymous. Pharmacists 'unable to maintain social distancing' at work and risk infection

Recommended PPE for ambulance staff paramedics transport and pharmacy

Pandemic preparedness of community pharmacies for COVID-19

Community pharmacists' exposure to COVID-19. Res Social Adm Pharm

Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information

Emergency preparedness and response (EP&R) by pharmacy professionals in India: Lessons from the COVID-19 pandemic and the way forward. Res Social Adm Pharm. 2020. 23. Google. Daily coronavirus cases in Kosova

5HCEpA%3A1593737189802&ei=5X_-Xo_UMMee4-EPv7Oa8A4&q=coronavirus+cases+kosova&oq=coronavirus+cases+kosova&gs_lcp=CgZwc3k tYWIQAzIECCMQJ1AAWABghBNoAHAAeACAAdoDiAHaA5IBAzQtMZgBAKoBB2d3cy13aXo&sc lient=psy-ab&ved=0ahUKEwjP2sDY7a_qAhVHzzgGHb-ZBu4Q4dUDCAw&uact=5